These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 767057)
41. Immune cytolysis of murine tumor cells mediated by xenogeneic "immune" RNA. Kern DH; Pilch YH Int J Cancer; 1974 May; 13(5):679-88. PubMed ID: 4843880 [No Abstract] [Full Text] [Related]
42. Cell-mediated and humoral immune reactions to human tumours. Baldwin RW; Embleton MJ; Jones JS; Langman MJ Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710 [No Abstract] [Full Text] [Related]
43. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation. Jurin M; Suit HD Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987 [No Abstract] [Full Text] [Related]
44. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy. Ablin RJ Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313 [No Abstract] [Full Text] [Related]
45. In vitro methods for assessment of antibody-mediated tumor immunity. Levy NL; Amos DB; Solovieff GV; dos Reis AP Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154 [No Abstract] [Full Text] [Related]
46. Humoral responses in tumor immunity: review of experimental findings. Mizejewski GJ Am J Med Sci; 1973 Nov; 266(5):359-69. PubMed ID: 4586922 [No Abstract] [Full Text] [Related]
47. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity. Jose DG; Seshadri R Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591 [No Abstract] [Full Text] [Related]
48. Clinical aspects of cancer immunity. Moore GE Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116 [No Abstract] [Full Text] [Related]
51. Immunologic approach to cancer. Mitchison NA Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297 [No Abstract] [Full Text] [Related]
52. Immunological aspects of neoplasia: a rational basis for immunotherapy. Ann Intern Med; 1971 Apr; 74(4):587-604. PubMed ID: 4927902 [No Abstract] [Full Text] [Related]
53. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy. Veltman LL; Kern DH; Pilch YH Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321 [No Abstract] [Full Text] [Related]
54. Immune reactions of the syngeneic host after the intradermal injection of tumor cells and microsomes. Bertschmann M; Lüscher EF Adv Exp Med Biol; 1973; 29(0):513-8. PubMed ID: 4212066 [No Abstract] [Full Text] [Related]
55. Studies of humoral and cell-mediated immunity in human melanoma. Mukherji B; Nathanson L; Clark DA Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586 [No Abstract] [Full Text] [Related]
56. [Immune surveillance in neoplasms]. Schneeweiss U Z Exp Chir; 1974; 7(4):204-15. PubMed ID: 4440030 [No Abstract] [Full Text] [Related]
58. Potentiation of cell-mediated lysis of xenogemeic tumor cells: the role of antiserum and effector cells. Sonis ST; Stelos P; Bancewicz J; Kolodkin A; Wilson RE Cell Immunol; 1976 May; 23(2):297-308. PubMed ID: 1084229 [No Abstract] [Full Text] [Related]
59. [Immunodepressive action of the tumor]. Belokhvostov AS Vopr Onkol; 1978; 24(3):99-106. PubMed ID: 347712 [No Abstract] [Full Text] [Related]
60. Possibilities and problems of immunologic intervention in cancer. Smith RT N Engl J Med; 1972 Aug; 287(9):439-50. PubMed ID: 4558044 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]